Siolta Therapeutics
Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases. The company was founded in 2016 by Nikole Kimes PhD.
2
Funding Rounds
$30.0m
Money raised
Overview
Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases. The company was founded in 2016 by Nikole Kimes PhD.
-
Website:
- Business model: B2C B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ni**** Ki*** Ph* |
|
- | |
| Su*** Ly*** Ph* | - | - | - |
Funding series
Funding Series Analysis
The company Siolta Therapeutics has raised a total of $30m in funding over 2 rounds.
Key Insights:
- Siolta Therapeutics Series B round, September 2020: $30m
Siolta Therapeutics Series B round, September 2020
$30m
Industries
Siolta Therapeutics is active in the following industries: